0
Skip to Content
About
Our Science
Our Pipeline
Investors
News
Contact
Search
Open Menu
Close Menu
Search
About
Our Science
Our Pipeline
Investors
News
Contact
Open Menu
Close Menu
About
Our Science
Our Pipeline
Investors
News
Contact
Search
Cornerstone investor Cantheon is kudos for OCT
4 Apr
Written By
Rita Ray
Rita Ray
Previous
Previous
The importance of patents
Next
Next
OCT Secures £1.205m to Advance Phase I Clinical Trial for Programme Two
